| Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risk evaluation and model development (REfraME) | |||
| Program: | H2020-EU.3.1, Ref No.: 643417 | ||
| Project Coordinator: | Giuseppe Legname, SISSA, Trieste, Italy | ||
| Duration: | Jan 1, 2015 – Dec 31, 2018 | ||
Participating investigators:
|
 |
||
| SyDAD Synaptic Dysfunction in Alzheimer Disease | ||
| Program: | H2020-EU.1.3.1., Ref No.: 676144 | |
| Project Coordinator: | Bengt Winblad, KAROLINSKA INSTITUTET, Sweden | |
| Duration: | Nov 1, 2015 – Oct 31, 2019 | |
 |
||
| Repetitive Subconcussive Head Impacts -Brain Alterations and Clinical Consequences | ||
| Program: | ERANET | |
| Project Coordinator: | Inga Katharina Koerte, MD PhD, Ludwig-Maximilians-Universität München, Department of Child and Adolescent Psychiatry, Psychosomatics, Germany | |
| Project Co-investigator: | Assoc. Prof. Peter Filipcik, RNDr, PhD | |
| Duration: | January 1, 2017 – 31 December 2019 | |
 |
||
| Targeting Western Diet-Induced Neurodegeneration | |
| WesternND – Cielenie neurodegenerácie indukovanej západnou diétou | |
| Program: | Horizon Europe |
| Project leader: | MSc. Basheer Neha, PhD. |
| Duration: | 1.6.2024 – 31.5.2027 |
| Lipid mediators and glial cells: key candidates for brain homeostasis | |
| Lipid mediators and glial cells: key candidates for brain homeostasis | |
| Program: | ICGEB |
| Project leader: | Mgr. Majerová Petra, PhD. |
| Duration: | 1.6.2024 – 31.5.2027 |
| – | |
| Alzheimer\’s Disease Diagnostics Innovation and Translation to Clinical Practice in Central Europe | |
| Program: | Horizon Europe |
| Project leader: | doc. MVDr. Žilka Norbert, DrSc. |
| Duration: | 1.1.2023 – 31.12.2026 |
| Disease-predisposing or resilience-promoting? Decoding the systems biology and behavioural predictors and determinants of the tipping point of stress | |
| PROGRESS – Predisponujúce k chorobám alebo podporujúce odolnosť? Dekódovanie biológie systémov, markerov a determinantov bodu zlomu stresu | |
| Program: | ERANET |
| Project leader: | prof. Ing. Jurišica Igor, DrSc. |
| Duration: | 1.12.2023 – 30.11.2026 |
| – | |
| Non-globular proteins in the era of Machine Learning | |
| Program: | COST |
| Project leader: | Ing. Cehlár Ondrej, PhD. |
| Duration: | 1.10.2022 – 31.10.2026 |
| Shorter- and longer-term mechanisms of multimodal interventions to prevent dementia | |
| Multi-MeMo – Krátkodobý a dlhodobý mechanizmus multimodálnej intervencie pre prevenciu demencie | |
| Program: | Horizon Europe |
| Project leader: | MVDr. Mgr. Smolek Tomáš, PhD. |
| Duration: | 1.4.2023 – 30.6.2026 |
| – | |
| Double-edged sword of Parkinson\’s disease: the study of extracellular vesicles as a mediator of pathology spreading and uniquesource of early diagnostics data | |
| Program: | ICGEB |
| Project leader: | MUDr. RNDr. Fričová Dominika, PhD. |
| Duration: | 1.5.2023 – 30.4.2026 |
| Neurovascular damage determines disease pathophysiology in pediatric mild traumatic brain injury: source of new biomarkers | |
| Neu-Vasc – Neurovaskulárne poškodenie určuje patofyziológiu ochorenia u detských pacientov po traumatickom poškodení mozgu: zdroj nových biomarkerov | |
| Program: | ERANET |
| Project leader: | doc. RNDr. Filipčík Peter, CSc. |
| Duration: | 1.1.2020 – 31.12.2025 |
| Developing novel nanopharmaceutics against bacterial infections at center nervous system | |
| Antineuropatho – Vývoj nových nanoliečiv proti bakteriálnym infekciám v centrálnom nervovom systéme | |
| Program: | ERANET |
| Project leader: | prof. MVDr. Bhide Mangesh Ramesh, PhD. |
| Duration: | 1.1.2022 – 31.12.2025 |
| A premotor disease signature for ALS | |
| premodiALS – Rukopis pre-motorického štádia amytrofnej laterálnej sklerózy | |
| Program: | Horizon 2020 |
| Project leader: | doc. MVDr. Žilka Norbert, DrSc. |
| Duration: | 1.9.2022 – 31.8.2025 |
| Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | |
| INTERTAU – Integrative structural biology of pathological tau protein, an appealing therapeutic target for Alzheimer´s disease modifying drugs | |
| Program: | Horizon 2020 |
| Project leader: | RNDr. Škrabana Rostislav, PhD. |
| Duration: | 1.6.2022 – 30.6.2025 |